The Journal of the Korean Society for Therapeutic Radiology and Oncology10.3857/jkstro.2009.27.3.1262009273126Division of the N2 Stage According to the Multiplicity of the Involved Nodal Stations May be Necessary in the N2-NSCLC Patients Who are Treated with Postoperative RadiotherapyHong In Yoon, Yong Bae Kim, Chang Geol Lee, Ik Jae Lee, Songyih Kim, Jun Won Kim, Joo Hang Kim, Byung Chul Cho, Jin Gu Lee, Kyung Young Chung,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2014.05.19362014901S655-S656Primary Tumor Volume, Bulky Adenopathy, and Number (But Not Location) of Involved Nodal Stations Predict Outcome in N2-N3 NSCLC Treated With Definitive Chemoradiation TherapyL. Miller, S. Garg, M. Batus, P. Bonomi, M. Fidler, J. Turian, D.J. Sher,
Radiotherapy and Oncology10.1016/s0167-8140(21)07639-82021161S985-S986PO-1188 Adjuvant Involved Field versus Elective Nodal Irradiation for N2 NSCLC: a dosimetric studyM. Mohammed, A. Mkanna, P. Ramia, D. Mahmoud, L. Hilal, F. Olleik, M. Dagher, Z. Ayoub, W. Jalbout, B. Shahine, F. Geara, B. Youssef,
Radiation Oncology10.1186/s13014-021-01912-42021161Effects of postoperative radiotherapy on cardiovascular-pulmonary disease mortality in patients with stage IIIA-N2 resected NSCLC: analysis of the SEER databaseXia Wang, Jiaqi Song, Jie Long, Zhimin Zeng, Anwen Liu,,
10.21203/ IIIA pathologic N2 non-small cell lung cancer patients may maximize benefit from preoperative radiotherapy: a population-based studyHongxia Duan, Long Liang, Shuanshuan Xie, Changhui Wang,
Cancer10.1002/cncr.265852012118184478-4485Postoperative radiotherapy for elderly patients with stage III lung cancerJuan P. Wisnivesky, Ethan A. Halm, Marcelo Bonomi, Cardinale Smith, Grace Mhango, Emilia Bagiella,
Radiotherapy and Oncology10.1016/j.radonc.2013.12.00520141103482-487Long-term survival of stage T4N0-1 and single station IIIA-N2 NSCLC patients treated with definitive chemo-radiotherapy using individualised isotoxic accelerated radiotherapy (INDAR)Bart Reymen, Angela van Baardwijk, Rinus Wanders, Jacques Borger, Anne-Marie C. Dingemans, Gerben Bootsma, Cordula Pitz, Ragnar Lunde, Wiel Geraedts, Philippe Lambin, Dirk De Ruysscher,
Journal of Thoracic Oncology10.1016/j.jtho.2019.08.244720191410S1097EP1.18-02 Pattern of Postoperative Recurrence and Clinical Value of Adjuvant Radiotherapy in Completely Resected Stage III/N2 EGFR-Mutant NSCLCJ. Ni, T. Guo, Y. Li, Z. Zhu,
Journal of Thoracic Oncology10.1016/j.jtho.2016.05.03720161191538-1549Patterns of Locoregional Relapses in Patients with Contemporarily Staged Stage III-N2 NSCLC Treated with Induction Chemotherapy and Resection: Implications for Postoperative Radiotherapy Target VolumesCharlotte Billiet, Dirk De Ruysscher, Stéphanie Peeters, Herbert Decaluwé, Johan Vansteenkiste, Christophe Dooms, Christophe M. Deroose, Paul De Leyn, Marc Hendrikx, Paul Bulens, Cécile Le Péchoux, Jeroen Mebis,
European Journal of Cancer10.1016/s0959-8049(17)30664-0201772S182Efficacy of postoperative radiotherapy in patients with pathological stage N2 EGFR wild type adenocarcinoma & squamous cell carcinoma lung cancerS.-Y. Wu,